Biotronik SE & Co KG - Product Pipeline Analysis, 2024 Update

Biotronik SE & Co KG - Product Pipeline Analysis, 2024 Update


Summary

Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as stent systems, balloon catheters, and guide wires for the treatment of peripheral, and coronary artery diseases. Biotronik has manufacturing facilities in Germany, Singapore, Switzerland, and the US. Biotronik is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biotronik SE & Co KG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biotronik SE & Co KG Company Overview
Biotronik SE & Co KG Company Snapshot
Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
Biotronik SE & Co KG – Pipeline Analysis Overview
Business Description
Biotronik SE & Co KG - Key Facts
Biotronik SE & Co KG - Major Products and Services
Biotronik SE & Co KG Pipeline Products by Development Stage
Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Biotronik SE & Co KG Pipeline Products Overview
AI Based Telemedicine - Myocardial Infarction
AI Based Telemedicine - Myocardial Infarction Product Overview
Allevia
Allevia Product Overview
AMS-2
AMS-2 Product Overview
Amvia Stellar
Amvia Stellar Product Overview
BIOVALVE Resheathable Transcatheter Aortic Valve
BIOVALVE Resheathable Transcatheter Aortic Valve Product Overview
Cardiac Conduction System
Cardiac Conduction System Product Overview
Coronary Stent System
Coronary Stent System Product Overview
Delivr
Delivr Product Overview
DREAMS 3G System
DREAMS 3G System Product Overview
DREAMS 3G System Clinical Trial
ElePulse System
ElePulse System Product Overview
ElePulse System Clinical Trial
Freesolve BTK RMS
Freesolve BTK RMS Product Overview
Hatriq
Hatriq Product Overview
Implantable Pressure Sensor
Implantable Pressure Sensor Product Overview
Magmaris Bioresorbable Magnesium Scaffold
Magmaris Bioresorbable Magnesium Scaffold Product Overview
Magmaris Bioresorbable Magnesium Scaffold Clinical Trial
ProGenic Pimecrolimus-eluting Coronary Stent System
ProGenic Pimecrolimus-eluting Coronary Stent System Product Overview
Renamic Neo Programmer
Renamic Neo Programmer Product Overview
Solvia Rise
Solvia Rise Product Overview
Solvia Rise Clinical Trial
Truelock
Truelock Product Overview
Truvia
Truvia Product Overview
Biotronik SE & Co KG - Key Competitors
Biotronik SE & Co KG - Key Employees
Biotronik SE & Co KG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biotronik SE & Co KG, Recent Developments
May 17, 2024: BIOMAG-I Two-Year Study Results Confirm Excellent Safety and Efficacy Profile for Freesolve, BIOTRONIK’s Newest Resorbable Magnesium Scaffold Innovation
May 13, 2024: New-Gen Resorbable Magnesium Scaffold Freesolve Enters BIOMAG-II Randomized Controlled Trial (RCT)
May 08, 2024: Biotronik SE Receives Additional Humanitarian Device Exemption (HDE) clearance for PK Papyrus Covered Coronary Stent
Apr 13, 2024: Biotronik SE & Co Receives Additional Humanitarian Device Exemption (HDE) Clearance for PK Papyrus Covered Coronary Stent
Mar 18, 2024: FDA Breakthrough Device Designation for BIOTRONIK Freesolve™ Below-the-Knee Resorbable Magnesium Scaffold (RMS)
Feb 08, 2024: New BIOlMASTER.Selectra 3D Study Highlights Exceptional Safety and Performance of BIOTRONIK’s Selectra 3D Guiding Catheter for CSP
Jan 29, 2024: BIOTRONIK's DX Technology Reaches Significant Milestone: 100,000 DX Devices Implanted
Oct 26, 2023: Five-Year Superiority Proven for Orsiro Des Over Xience Des in Stemi Patients
Oct 05, 2023: Newly Published Data Supports Effectiveness of BIOTRONIK Neuro’s RESONANCE Stimulation
Sep 14, 2023: BIOLUX P-III BENELUX All-Comers Registry Demonstrates Safety and Efficacy of BIOTRONIK’s Drug-Coated Balloon in Isolated Popliteal Lesions at 24 Months
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Biotronik SE & Co KG Pipeline Products by Equipment Type
Table 3: Biotronik SE & Co KG Pipeline Products by Indication
Table 4: Biotronik SE & Co KG, Key Facts
Table 5: Biotronik SE & Co KG, Major Products and Services
Table 6: Biotronik SE & Co KG Number of Pipeline Products by Development Stage
Table 7: Biotronik SE & Co KG Pipeline Products Summary by Development Stage
Table 8: Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Table 9: Biotronik SE & Co KG Ongoing Clinical Trials Summary
Table 10: AI Based Telemedicine - Myocardial Infarction - Product Status
Table 11: AI Based Telemedicine - Myocardial Infarction - Product Description
Table 12: Allevia - Product Status
Table 13: Allevia - Product Description
Table 14: AMS-2 - Product Status
Table 15: AMS-2 - Product Description
Table 16: Amvia Stellar - Product Status
Table 17: Amvia Stellar - Product Description
Table 18: BIOVALVE Resheathable Transcatheter Aortic Valve - Product Status
Table 19: BIOVALVE Resheathable Transcatheter Aortic Valve - Product Description
Table 20: Cardiac Conduction System - Product Status
Table 21: Cardiac Conduction System - Product Description
Table 22: Coronary Stent System - Product Status
Table 23: Coronary Stent System - Product Description
Table 24: Delivr - Product Status
Table 25: Delivr - Product Description
Table 26: DREAMS 3G System - Product Status
Table 27: DREAMS 3G System - Product Description
Table 28: DREAMS 3G System - BIOTRONIK - Safety and Clinical Performance of the - Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries
Table 29: DREAMS 3G System - BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A Randomized Controlled Trial
Table 30: ElePulse System - Product Status
Table 31: ElePulse System - Product Description
Table 32: ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
Table 33: Freesolve BTK RMS - Product Status
Table 34: Freesolve BTK RMS - Product Description
Table 35: Hatriq - Product Status
Table 36: Hatriq - Product Description
Table 37: Implantable Pressure Sensor - Product Status
Table 38: Implantable Pressure Sensor - Product Description
Table 39: Magmaris Bioresorbable Magnesium Scaffold - Product Status
Table 40: Magmaris Bioresorbable Magnesium Scaffold - Product Description
Table 41: Magmaris Bioresorbable Magnesium Scaffold - Biotroniks - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV
Table 42: Magmaris Bioresorbable Magnesium Scaffold - Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds Magmaris (MAGIC Registry)
Table 43: Magmaris Bioresorbable Magnesium Scaffold - RMS (Resorbable Magnesium Scaffolds) Registry
Table 44: Magmaris Bioresorbable Magnesium Scaffold - Scaffold Implantation in Emilia-Romagna
Table 45: ProGenic Pimecrolimus-eluting Coronary Stent System - Product Status
Table 46: ProGenic Pimecrolimus-eluting Coronary Stent System - Product Description
Table 47: Renamic Neo Programmer - Product Status
Table 48: Renamic Neo Programmer - Product Description
Table 49: Solvia Rise - Product Status
Table 50: Solvia Rise - Product Description
Table 51: Solvia Rise - BIO|CONCEPT.Amvia, First in Human Study for the Amvia/Solvia Pacemaker Family
Table 52: Solvia Rise - BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
Table 53: Truelock - Product Status
Table 54: Truelock - Product Description
Table 55: Truvia - Product Status
Table 56: Truvia - Product Description
Table 57: Biotronik SE & Co KG, Key Employees
Table 58: Biotronik SE & Co KG, Subsidiaries
Table 59: Glossary
List of Figures
Figure 1: Biotronik SE & Co KG Pipeline Products by Equipment Type
Figure 2: Biotronik SE & Co KG Pipeline Products by Development Stage
Figure 3: Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings